Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers

PURPOSE: We developed and validated a contrast-enhanced spectral mammography (CESM)-based radiomics nomogram to predict neoadjuvant chemotherapy (NAC)-insensitive breast cancers prior to treatment. METHODS: We enrolled 117 patients with breast cancer who underwent CESM examination and NAC treatment...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Wang, Zhongyi, Lin, Fan, Ma, Heng, Shi, Yinghong, Dong, Jianjun, Yang, Ping, Zhang, Kun, Guo, Na, Zhang, Ran, Cui, Jingjing, Duan, Shaofeng, Mao, Ning, Xie, Haizhu
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7937952/
https://ncbi.nlm.nih.gov/pubmed/33692950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.605230
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky